Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trial

Journal:
Nature Medicine
Published:
DOI:
10.1038/s41591-026-04307-8
Affiliations:
13
Authors:
15
Go to article
Institutions Authors Share
Arrowhead Pharmaceuticals, United States of America (USA)
4.000000
 0.27
Stanford University School of Medicine, United States of America (USA)
2.000000
 0.13
New Zealand Clinical Research (NZCR), New Zealand
1.000000
 0.07
Royal Prince Alfred Hospital (RPAH), USYD, Australia
1.000000
 0.07
Middlemore Hospital, New Zealand
1.000000
 0.07
Royal Adelaide Hospital (RAH), Australia
1.000000
 0.07
NYU Langone Health, United States of America (USA)
1.000000
 0.07
Western University (UWO), Canada
1.000000
 0.07
Texas Heart Institute (THI), United States of America (USA)
1.000000
 0.07
The University of Western Australia (UWA), Australia
0.500000
 0.03
Royal Perth Hospital, Australia
0.500000
 0.03
University of Montreal (UdeM), Canada
0.500000
 0.03
ECOGENE-21 Biocluster, Canada
0.500000
 0.03
Interested in Cardiovascular Medicine and Haematology?